Gilead Sciences Announces Third Quarter 2013 Financial Results

30-10-2013 Business Wire HealthComments (0)

BiotechnologyGilead Sciences

Gilead Sciences, Inc. (Nasdaq: GILD) announced today its results of operations for the quarter ended September 30, 2013. Total revenues for the third quarter of 2013 increased 15 percent to $2.78 billion, from $2.43 billion for the third quarter of 2012. Product sales increased 15 percent to $2.71 billion for the third quarter of 2013 compared to $2.36 billion for the third quarter of 2012. Net income for the third quarter of 2013 was $788.6 million, or...

Read more on Business Wire Health

More on this story...

New HIV drugs drive Gilead Sciences 3rd-qtr growth
30-10-2013

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top